The open-label study evaluated a daily dose of 5 grams of creatine monohydrate paired with 600 milligrams of alpha-glycerylphosphorylcholine. Beyond objective cognitive testing, the data relied on participant reports to gauge shifts in focus, mood, and physical stamina. Within the first week, 79% of users noted improvements in clarity or performance, with the average time to perceive a benefit reaching just two days.
In section Releases
Thorne Study Links Creatine and Alpha-GPC to Cognitive Gains
More than 60% of participants in a new 30-day study demonstrated measurable improvements in cognitive performance after using Thorne’s Creatine + Alpha-GPC supplement. The research, which tracked 105 active adults, suggests the formulation effectively bridges the gap between physical endurance and mental clarity through a combination of targeted ingredients.
By the end of the four-week period, the reported gains remained significant. Participants cited a 96% increase in motivation and an 89% boost in focus, while 83% reported higher energy levels. The product, which holds NSF Certified for Sport status, also showed positive results for exercise recovery, with 70% of subjects noting improved recovery times. Ken Rowe, Thorne’s Chief R&D Officer, emphasized that the company prioritizes testing finished formulations rather than individual ingredients to ensure consumers understand the real-world outcomes of their supplements. This project is part of a broader research initiative for the company, which has already completed five studies in 2026 and plans to initiate over 30 more in the coming year.
Comments (0)
No comments yet. Be the first!